BioSpace News Archive

Food Allergy Centers of Distinction in California, Florida, Illinois and Minnesota increase access to cutting-edge care, more promising future

PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced the award of a funding grant from the National Institutes of Health (NIH) under the Rapid Acceleration of Diagnostics (RADx SM) program.

Syft®, a leading national provider of healthcare inventory control and end-to-end supply chain cost management software and services, today announced the launch of a new decedent management and tracking solution built on the Syft Synergy® enterprise supply chain management platform.

Regent Pacific Group Limited (“Regent Pacific” or the “Company” and together with its subsidiaries, the “Group"; Hong Kong stock code: 00575), a specialist healthcare, wellness and life sciences investment group, has signed legally binding Share Purchase Agreements with the shareholders and DLI ESOP award recipients of Deep Longevity, Inc

Asymchem, a leading global CDMO service provider, announced a strategic investment in Snapdragon Chemistry, a private U.S. chemical technology company focused on the design and development of efficient and sustainable manufacturing processes for pharmaceutical applications.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Wells Fargo Virtual Healthcare Conference. Mark Guinan , Executive Vice President and CFO will discuss the company’s vision, goals and two-point strategy to accelerate growt

Alzheimer’s (including MCI)-focused research which reports on the effects of COVID-19 and insights surrounding the new diagnostic agent, TAUVID™

Surgeon’s performance using AR+ for a total knee replacement operation marks a further milestone in advanced surgery Vuzix to host webinar for smart glasses in medical use cases during and beyond the COVID-19 pandemic [02-September-2020] ROCHESTER, N.Y. , Sept. 2, 2020 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leadi

Aeglea BioTherapeutics, Inc. announced it will participate in three investor conferences in September 2020, including presenting at the H.C. Wainwright 22nd Annual Global Investment Conference being held virtually on September 14-16, 2020.

Prothena Corporation plc announced that in connection with hiring two new employees, the compensation committee of the Company’s board of directors granted the individuals hired by the Company, in the aggregate, options to purchase 60,000 ordinary shares of the Company.